Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer, March 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 346 articles:
HTML format


 

Single Articles

  1. TAN X, Yang J, Jiang J, Wang W, et al
    Significant Growth Inhibition by a Bispecific Affibody Targeting Oncoprotein E7 in both HPV16 and 18 Positive Cervical Cancer in vitro and in vivo.
    Eur J Pharm Sci. 2022 Mar 1:106156. doi: 10.1016/j.ejps.2022.106156.
    PubMed    
    Abstract available

  2. CHUANG LT, Temin S, Berek JS
    Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update.
    JCO Glob Oncol. 2022;8:e2200027.
    PubMed    
    Abstract available

  3. BONDE J, Schroll JB, Kristensen BK, Lynge E, et al
    [Phased implementation of HPV-based cervical cancer screening in Denmark].
    Ugeskr Laeger. 2022;184.
    PubMed    
    Abstract available

  4. SISEHO KN, Omoruyi BE, Okeleye BI, Okudoh VI, et al
    Women's perception of cervical cancer pap smear screening.
    Nurs Open. 2022 Mar 4. doi: 10.1002/nop2.1196.
    PubMed    
    Abstract available

  5. LIU G, Mugo NR, Bayer C, Rao DW, et al
    Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence.
    EClinicalMedicine. 2022;45:101306.
    PubMed    
    Abstract available

  6. CHINULA L, McGue S, Smith JS, Saidi F, et al
    A novel cervical cancer screen-triage-treat demonstration project with HPV self-testing and thermal ablation for women in Malawi: Protocol for a single-arm prospective trial.
    Contemp Clin Trials Commun. 2022;26:100903.
    PubMed    
    Abstract available

  7. SUN L, Yang L, Liu X, Tang L, et al
    Optimization of Cervical Cancer Screening: A Stacking-Integrated Machine Learning Algorithm Based on Demographic, Behavioral, and Clinical Factors.
    Front Oncol. 2022;12:821453.
    PubMed    
    Abstract available

  8. ZHANG F, Zhang H, Qian W, Xi Y, et al
    Matrine exerts antitumor activity in cervical cancer by protective autophagy via the Akt/mTOR pathway in vitro and in vivo.
    Oncol Lett. 2022;23:110.
    PubMed    
    Abstract available

  9. KASSAMAN D, Mushani T, Kiraithe P, Brownie S, et al
    Fear, faith and finances: health literacy experiences of English and Swahili speaking women newly diagnosed with breast and cervical cancer.
    Ecancermedicalscience. 2022;16:1350.
    PubMed    
    Abstract available

  10. DHOKOTERA T, Asangbeh S, Bohlius J, Singh E, et al
    Cervical cancer in women living in South Africa: a record linkage study of the National Health Laboratory Service and the National Cancer Registry.
    Ecancermedicalscience. 2022;16:1348.
    PubMed    
    Abstract available

  11. ZHANG J, Fan J, Skwarczynski M, Stephenson RJ, et al
    Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances.
    Int J Nanomedicine. 2022;17:869-900.
    PubMed    
    Abstract available

  12. NGUYEN DTN, Simms KT, Keane A, Mola G, et al
    Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea.
    BMJ Glob Health. 2022;7.
    PubMed    
    Abstract available

  13. BARBEN J, Kamga AM, Dabakuyo-Yonli TS, Hacquin A, et al
    Cervical cancer in older women: Does age matter?
    Maturitas. 2022;158:40-46.
    PubMed    
    Abstract available

  14. HU L, Zhou M, Xue L, Zhang J, et al
    Circular RNA hsa_circ_0011385 contributes to cervical cancer progression through sequestering miR-149-5p and increasing PRDX6 expression.
    Reprod Biol. 2022;22:100619.
    PubMed    
    Abstract available

  15. MOTA SDS, Otano SS, Murta EFC, Nomelini R, et al
    Blood count and fasting blood glucose level in the assessment of prognosis and survival in advanced cervical cancer.
    Rev Assoc Med Bras (1992). 2022;68:234-238.
    PubMed    
    Abstract available

  16. OKONOGI N, Usui H, Murata K, Hori M, et al
    Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.
    BMJ Open. 2022;12:e056424.
    PubMed    
    Abstract available

  17. ZHANG J, Song C, Liu B
    Efficacy of cisplatin plus paclitaxel as chemotherapy in patients with cervical cancer after laparoscopic nerve-sparing extensive hysterectomy and its effect on immune function.
    Pak J Pharm Sci. 2022;35.
    PubMed    
    Abstract available

  18. HAN Y, Bai C, He XM, Ren QL, et al
    P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells.
    Purinergic Signal. 2022 Mar 2. pii: 10.1007/s11302-022-09854.
    PubMed    
    Abstract available

  19. LI Y, Meng F, Sui C, Wang Y, et al
    CircWHSC1 expedites cervical cancer progression via miR-532-3p/LTBP2 axis.
    Mol Cell Biochem. 2022 Mar 2. pii: 10.1007/s11010-022-04395.
    PubMed    
    Abstract available

  20. ZHANG L, Cai Y, Tian C, Li Y, et al
    LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and ce
    J Obstet Gynaecol Res. 2022 Mar 1. doi: 10.1111/jog.15209.
    PubMed    
    Abstract available

  21. WHALEN-BROWNE M, Talavlikar R, Brown G, McBrien K, et al
    Cervical Cancer Screening by Refugee Category in a Refugee Health Primary Care Clinic in Calgary, Canada, 2011-2016.
    J Immigr Minor Health. 2022 Mar 1. pii: 10.1007/s10903-022-01345.
    PubMed    
    Abstract available

  22. DAMAST S, Tien CJ, Young M, Altwerger G, et al
    Single application hybrid interstitial brachytherapy for cervical cancer: an institutional approach during the COVID-19 pandemic.
    J Contemp Brachytherapy. 2022;14:66-71.
    PubMed    
    Abstract available

  23. KELLAS-SLECZKA S, Wojcieszek P, Szlag M, Stankiewicz M, et al
    Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center results.
    J Contemp Brachytherapy. 2022;14:43-51.
    PubMed    
    Abstract available

  24. ROSS S, Ragupathy K
    Role of an IUCD in managing patients with post-LLETZ cervical stenosis.
    BMJ Case Rep. 2022;15.
    PubMed    
    Abstract available

  25. CHEN HJ, Li NL, Gu Q, Zhang GM, et al
    Cervical cancer cell proliferation inhibition by vanillin oxime through HIF1alpha expression inhibition, ERK1/2 and Akt protein down-regulation.
    Acta Biochim Pol. 2022 Mar 2. pii: 5685. doi: 10.18388/abp.2020_5685.
    PubMed    
    Abstract available

  26. HE K, Li P, Zhang Z, Liu J, et al
    Intraoperative near-infrared fluorescence imaging can identify pelvic nerves in patients with cervical cancer in real time during radical hysterectomy.
    Eur J Nucl Med Mol Imaging. 2022 Mar 1. pii: 10.1007/s00259-022-05686.
    PubMed    
    Abstract available

  27. SHYLASREE TS, Gurram L, Das U
    Para-aortic lymph node involvement in cervical cancer: Implications for staging, outcome and treatment.
    Indian J Med Res. 2022 Feb 28. pii: 338111. doi: 10.4103/ijmr.IJMR_4183.
    PubMed    
    Abstract available

  28. KUMAR A, Chopra S, Gupta S
    Contribution of Tata Memorial Centre, India, to cervical cancer care: Journey of two decades.
    Indian J Med Res. 2022 Feb 28. pii: 338110. doi: 10.4103.
    PubMed    
    Abstract available

  29. GEORGE R, Rai B
    Practical aspects of palliative care & palliative radiotherapy in incurable cervical cancer.
    Indian J Med Res. 2022 Feb 28. pii: 338107. doi: 10.4103/ijmr.IJMR_1642.
    PubMed    
    Abstract available

  30. DAS AP, Saini S, Agarwal SM
    A comprehensive meta-analysis of non-coding polymorphisms associated with precancerous lesions and cervical cancer.
    Genomics. 2022 Feb 25:110323. doi: 10.1016/j.ygeno.2022.110323.
    PubMed    
    Abstract available

  31. PALAIA I, Santangelo G, Caruso G, Perniola G, et al
    Long-term Quality of Life and Sexual Function After Neoadjuvant Chemotherapy and Radical Surgery for Locally Advanced Cervical Cancer.
    J Sex Med. 2022 Feb 25. pii: S1743-6095(22)00553.
    PubMed    
    Abstract available

  32. LICHTER K, Anakwenze C, MacDuffie E, Bhatia R, et al
    Treatment of cervical cancer: overcoming challenges in access to brachytherapy.
    Expert Rev Anticancer Ther. 2022 Mar 1. doi: 10.1080/14737140.2022.2047936.
    PubMed    
    Abstract available

  33. KISELEVA M, Omar MM, Boisselier E, Selivanova SV, et al
    A Three-Dimensional Printable Hydrogel Formulation for the Local Delivery of Therapeutic Nanoparticles to Cervical Cancer.
    ACS Biomater Sci Eng. 2022 Feb 28. doi: 10.1021/acsbiomaterials.1c01399.
    PubMed    
    Abstract available

  34. DATTA D, Aggarwal D, Balakrishnan S, Varshney VK, et al
    Metastasis from Cervical Cancer Presenting as a Pancreatic Head Mass - an Unexpected Diagnosis!
    J Gastrointest Cancer. 2022 Feb 28. pii: 10.1007/s12029-022-00811.
    PubMed    
    Abstract available

  35. GALATI L, Combes JD, Le Calvez-Kelm F, McKay-Chopin S, et al
    Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.
    Microbiol Spectr. 2022 Feb 28:e0148021. doi: 10.1128/spectrum.01480.
    PubMed    
    Abstract available

  36. LOHIYA A, Daniel RA, Kumar D, Varghese C, et al
    Effectiveness of Visual Inspection with Acetic Acid (VIA) Screening on Cervical Cancer Mortality and Incidence - A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2022;23:399-407.
    PubMed    
    Abstract available

  37. BENNACEF AC, Khodja AA, Abou-Bekr FA, Ndao T, et al
    Costs and Resource Use Among Patients with Cervical Cancer, Cervical Intraepithelial Neoplasia, and Genital Warts in Algeria.
    J Health Econ Outcomes Res. 2022;9:31-38.
    PubMed    
    Abstract available

  38. WANG P, Zhang L, Zhang J, Xu G, et al
    MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1.
    Exp Ther Med. 2022;23:233.
    PubMed    
    Abstract available

  39. PIYATHILAKE CJ, Badiga S, Simons JL, Bell WC, et al
    HPV E1 qPCR, a Low-Cost Alternative Assay to Roche Diagnostic Linear Array is Effective in Identifying Women at Risk for Developing Cervical Cancer.
    Int J Womens Health. 2022;14:257-266.
    PubMed    
    Abstract available

  40. YU XL, Wu MF, Ding L, Yang J, et al
    Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer.
    Cancer Manag Res. 2021;13:9297-9304.
    PubMed    
    Abstract available

  41. YANG P, Yu Y, Zhong N
    Efficacy of humanistic care and psychological intervention of medical staff in patients with cervical cancer undergoing post-installation treatment.
    Asian J Surg. 2022 Feb 24. pii: S1015-9584(22)00120.
    PubMed    


  42. QU Y, Zhu H, Kong C, Zheng X, et al
    RNA modification "writer"-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer.
    Clin Transl Oncol. 2022 Feb 27. pii: 10.1007/s12094-022-02787.
    PubMed    
    Abstract available

  43. CHAUHAN R, Trivedi V, Rani R, Singh U, et al
    Pre-treatment hematological parameters as a cost effective predictive marker for response to concurrent chemo radiation in locally advanced cervical cancer.
    Cancer Treat Res Commun. 2022;31:100539.
    PubMed    
    Abstract available

  44. MOHANTY S, Yadav P, Lakshminarayanan H, Sharma P, et al
    RETRA induces necroptosis in cervical cancer cells through RIPK1, RIPK3, MLKL and increased ROS production.
    Eur J Pharmacol. 2022;920:174840.
    PubMed    
    Abstract available

  45. JIANG L, Jin H, Gong S, Han K, et al
    LncRNA KCNQ1OT1-mediated cervical cancer progression by sponging miR-1270 as a ceRNA of LOXL2 through PI3k/Akt pathway.
    J Obstet Gynaecol Res. 2022 Feb 25. doi: 10.1111/jog.15177.
    PubMed    
    Abstract available

  46. ROMERO D
    Benefit with cemiplimab in cervical cancer.
    Nat Rev Clin Oncol. 2022 Feb 25. pii: 10.1038/s41571-022-00613.
    PubMed    


  47. WANG C, Kuang L, Han L
    Retraction notice to "MiR-374b increases the CIK expression and mediates biological function changes in cervical cancer cells by targeting the PD-1/PD-L1 signaling pathway" [J. Reprod. Immunol. 143C (2021) 103265].
    J Reprod Immunol. 2022;150:103498.
    PubMed    


  48. DAI J, Wang L, Li L, Tian X, et al
    Retraction notice to "Interplay of microRNAs to genetic, epigenetic, copy number variations of cervical cancer related genes" [J. Reprod. Immunol. 142C (2020) 103184].
    J Reprod Immunol. 2022;150:103496.
    PubMed    


  49. MATSUO K, Klar M, Ciccone MA, Nusbaum DJ, et al
    Incorporation of sentinel lymph node biopsy in cervical cancer surgery: Recent U.S. trends.
    Eur J Surg Oncol. 2022 Feb 18. pii: S0748-7983(22)00112.
    PubMed    
    Abstract available

  50. LEE CY, Hsin MC, Chen PN, Lin CW, et al
    Arctiin Inhibits Cervical Cancer Cell Migration and Invasion through Suppression of S100A4 Expression via PI3K/Akt Pathway.
    Pharmaceutics. 2022;14.
    PubMed    
    Abstract available

  51. MAFFINI CF, Collaco LM, Sebastiao APM, Zanine RM, et al
    Colposcopic Findings and Diagnosis in Low-Income Brazilian Women with ASC-H pap Smear Results.
    Rev Bras Ginecol Obstet. 2022;44:178-186.
    PubMed    
    Abstract available

  52. STOJANOVIC MM, Rancic NK, Andjelkovic Apostolovic MR, Ignjatovic AM, et al
    Temporal Changes in Incidence Rates of the Most Common Gynecological Cancers in the Female Population in Central Serbia.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  53. BALAKRISHNAN CK, Tye GJ, Balasubramaniam SD, Kaur G, et al
    CD74 and HLA-DRA in Cervical Carcinogenesis: Potential Targets for Antitumour Therapy.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  54. NOULALA CGT, Ouete JLN, Atangana AF, Mbahbou GTB, et al
    Soyauxinine, a New Indolopyridoquinazoline Alkaloid from the Stem Bark of Araliopsis soyauxii Engl. (Rutaceae).
    Molecules. 2022;27.
    PubMed    
    Abstract available

  55. ZHANG W, Lu Y, Zang Y, Han J, et al
    Photodynamic Therapy and Multi-Modality Imaging of Up-Conversion Nanomaterial Doped with AuNPs.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  56. ALAM Z, Deol H, Dean JA, Janda M, et al
    Reasons behind Low Cervical Screening Uptake among South Asian Immigrant Women: A Qualitative Exploration.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  57. NOROOZI Z, Shamsara M, Valipour E, Esfandyari S, et al
    Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cells.
    Sci Rep. 2022;12:2224.
    PubMed    
    Abstract available

  58. HAGEGE M, Ali-Hamadi A, Oddou S, Serhal R, et al
    Health, illness and cancer in Mayotte: Multicultural experiences in a medically underserved French Territory.
    Bull Cancer. 2022;109:241-245.
    PubMed    
    Abstract available

  59. ZHU X, Li S, Luo J, Ying X, et al
    Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes.
    Front Immunol. 2022;13:801639.
    PubMed    
    Abstract available

  60. CHARATSI D, Vanakara P, Evaggelopoulou E, Simopoulou F, et al
    Vaginal dilator use to promote sexual wellbeing after radiotherapy in gynecological cancer survivors.
    Medicine (Baltimore). 2022;101:e28705.
    PubMed    
    Abstract available

  61. VORSTERS A, Bosch FX, Poljak M, Waheed DE, et al
    HPV prevention and control - The way forward.
    Prev Med. 2022;156:106960.
    PubMed    
    Abstract available

  62. MURESU N, Sotgiu G, Marras S, Gentili D, et al
    Cervical Screening in North Sardinia (Italy): Genotype Distribution and Prevalence of HPV among Women with ASC-US Cytology.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  63. KOMATSU H, Okawa M, Hikino K, Iida Y, et al
    A simplified procedure of nerve-sparing radical hysterectomy.
    J Obstet Gynaecol Res. 2022;48:766-773.
    PubMed    
    Abstract available

  64. MANE A, Limaye S, Patil L, Kulkarni-Kale U, et al
    Genetic variations in the long control region of human papillomavirus type 16 isolates from India: implications for cervical carcinogenesis.
    J Med Microbiol. 2022;71.
    PubMed    
    Abstract available

  65. NAGASE S, Ohta T, Takahashi F, Yamagami W, et al
    Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2018 and Annual Treatment Report for 2013.
    J Obstet Gynaecol Res. 2022;48:541-552.
    PubMed    
    Abstract available

  66. HAGEGE M, Chirpaz E, Khettab M
    Health, illness and cancer in Reunion Island: Health services in a diverse but aging French territory.
    Bull Cancer. 2022;109:226-231.
    PubMed    
    Abstract available

  67. WANG L, Wang F, Fu S, Zhang C, et al
    Analysis of genetic variation in human papillomavirus type 16 E1 and E2 in women with cervical infection in Xinjiang, China.
    BMC Med Genomics. 2021;14:268.
    PubMed    
    Abstract available

  68. KASA AS, Dagget T, Beyene Y, Dessie G, et al
    Precancerous cervical lesion in Ethiopia: systematic review and meta-analysis.
    Syst Rev. 2021;10:287.
    PubMed    
    Abstract available

  69. STALEY H, Shiraz A, Shreeve N, Bryant A, et al
    Interventions targeted at women to encourage the uptake of cervical screening.
    Cochrane Database Syst Rev. 2021;9:CD002834.
    PubMed    
    Abstract available

  70. KAWASE R, Suzuki S
    Women with Atypical Glandular Cells in Japan: The Clinical Significance and Utility of HPV-DNA Testing in Korean Women with Atypical Glandular Cells in Cervical Pap Tests.
    Cancer Invest. 2022;40:234.
    PubMed    


  71. ACHAT HM, Hartcher NM, Lamb K, Stubbs J, et al
    Why would a woman screen? Facilitators and barriers for women least likely to participate in cervical screening in Australia.
    Public Health Res Pract. 2021;31.
    PubMed    


  72. SHOU H, Wu J, Tang N, Wang B, et al
    Calcification-Based Cancer Diagnosis and Therapy.
    ChemMedChem. 2022;17:e202100339.
    PubMed    
    Abstract available

  73. FEI Z, Qin L, Luo F, Yu Y, et al
    CircRNA circ-ATAD1 Is Upregulated in Cervical Squamous Cell Carcinoma and Regulates Cell Proliferation and Apoptosis by Suppressing the Maturation of miR-218.
    Reprod Sci. 2021;28:2982-2988.
    PubMed    
    Abstract available

  74. NAZARI Z, Torabizadeh G, Khalilian A, Ghadami S, et al
    Is cryotherapy effective in all women with low-grade cervical intraepithelial neoplasia?
    Eur Rev Med Pharmacol Sci. 2021;25:4211-4218.
    PubMed    
    Abstract available

  75. MCBRIDE E, Marlow LAV, Chilcot J, Moss-Morris R, et al
    Distinct Illness Representation Profiles Are Associated With Anxiety in Women Testing Positive for Human Papillomavirus.
    Ann Behav Med. 2022;56:78-88.
    PubMed    
    Abstract available

  76. OLIVEIRA AKDSG, Jacyntho CMA, Tso FK, Boldrini NAT, et al
    HPV infection - Screening, diagnosis and management of HPV-induced lesions.
    Rev Bras Ginecol Obstet. 2021;43:240-246.
    PubMed    


  77. NEVES NA, Teixeira JC, Santos ALF, Goncalves MAG, et al
    Vaccination in women with cancer.
    Rev Bras Ginecol Obstet. 2021;43:150-154.
    PubMed    


  78. LI W, Lei W, Chao X, Song X, et al
    Genomic alterations caused by HPV integration in a cohort of Chinese endocervical adenocarcinomas.
    Cancer Gene Ther. 2021;28:1353-1364.
    PubMed    
    Abstract available

  79. DI MEO N, Conforti C, Nan K, Romano A, et al
    Primary malignant melanoma of uterine cervix.
    Ital J Dermatol Venerol. 2021;156.
    PubMed    


  80. KYRGIOU M, Moscicki AB
    Vaginal Microbiome and Cervical Cancer.
    Semin Cancer Biol. 2022 Mar 8. pii: S1044-579X(22)00061.
    PubMed    
    Abstract available


  81. Correction to: Long Noncoding RNA LINC00899/miR-944/ESR1 Axis Regulates Cervical Cancer Cell Proliferation, Migration, and Invasion by Chen, et al. J Interferon Cytokine Res. 2021;41(6):220-233; doi: 10.1089/jir.2021.0023.
    J Interferon Cytokine Res. 2022 Mar 11. doi: 10.1089/jir.2021.0023.
    PubMed    


  82. LV Y, Wang M, Chen M, Wang D, et al
    hsa_circ_0119412 overexpression promotes cervical cancer progression by targeting miR-217 to upregulate anterior gradient 2.
    J Clin Lab Anal. 2022 Mar 11:e24236. doi: 10.1002/jcla.24236.
    PubMed    
    Abstract available

  83. WU Y, Liu C, Wang W, Tian L, et al
    Study on Appropriate Rectal Volume for External Irradiation in Patients With Cervical Cancer.
    Front Oncol. 2022;12:814414.
    PubMed    
    Abstract available

  84. SUO X, Wang Z, Zhu Y
    Application effect of sevoflurane combined with remifentanil intravenous inhalation anesthesia in patients undergoing laparoscopic radical resection of cervical cancer.
    Am J Transl Res. 2022;14:1034-1042.
    PubMed    
    Abstract available

  85. DEEPTI P, Pasha A, Vishambhar Kumbhakar D, Doneti R, et al
    Overexpression of Secreted Phosphoprotein 1 (SPP1) predicts poor survival in HPV positive cervical cancer.
    Gene. 2022 Mar 7:146381. doi: 10.1016/j.gene.2022.146381.
    PubMed    
    Abstract available

  86. FU X, Duan Z, Lu X, Zhu Y, et al
    SND1 Promotes Radioresistance in Cervical Cancer Cells by Targeting the DNA Damage Response.
    Cancer Biother Radiopharm. 2022 Mar 10. doi: 10.1089/cbr.2021.0371.
    PubMed    
    Abstract available

  87. NGU SF, Lau LSK, Li J, Wong GCY, et al
    Human Papillomavirus Self-Sampling for Primary Cervical Cancer Screening in Under-Screened Women in Hong Kong during the COVID-19 Pandemic.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  88. KOKABU T, Masui K, Tarumi Y, Noguchi N, et al
    3D-Image-Guided Multi-Catheter Interstitial Brachytherapy for Bulky and High-Risk Stage IIB-IVB Cervical Cancer.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  89. KANAVATI F, Hirose N, Ishii T, Fukuda A, et al
    A Deep Learning Model for Cervical Cancer Screening on Liquid-Based Cytology Specimens in Whole Slide Images.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  90. DOGAN N, Fiskin G
    Attitudes towards prevention of cervical cancer and early diagnosis among female academicians.
    J Obstet Gynaecol Res. 2022 Mar 9. doi: 10.1111/jog.15218.
    PubMed    
    Abstract available

  91. TANTENGCO OAG, Nakura Y, Yoshimura M, Nishiumi F, et al
    Co-infection of human papillomavirus and other sexually transmitted bacteria in cervical cancer patients in the Philippines.
    Gynecol Oncol Rep. 2022;40:100943.
    PubMed    
    Abstract available

  92. SUN J, Yuan J
    Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer.
    Bioengineered. 2022;13:7579-7591.
    PubMed    
    Abstract available

  93. YANG H, Qu X, Huang J, Zhang F, et al
    E2F4 may be a core transcription factor in the lncRNA-TF regulatory network in cervical cancer.
    J Clin Lab Anal. 2022 Mar 9:e24322. doi: 10.1002/jcla.24322.
    PubMed    
    Abstract available

  94. SCHARL S, Weidenbaecher CB, Hugo C, Brambs CE, et al
    First experiences with PET-MRI/CT in radiotherapy planning for cervical cancer.
    Arch Gynecol Obstet. 2022 Mar 9. pii: 10.1007/s00404-022-06395.
    PubMed    
    Abstract available

  95. QILIN Z, Peng B, Ang Q, Weijuan J, et al
    The feasibility study on the generalization of deep learning dose prediction model for volumetric modulated arc therapy of cervical cancer.
    J Appl Clin Med Phys. 2022 Mar 9:e13583. doi: 10.1002/acm2.13583.
    PubMed    
    Abstract available

  96. MOURYA A, Aggarwal LM, Choudhary S
    Evolution of Brachytherapy Applicators for the Treatment of Cervical Cancer.
    J Med Phys. 2021;46:231-243.
    PubMed    
    Abstract available

  97. KRUCZKOWSKI M, Drabik-Kruczkowska A, Marciniak A, Tarczewska M, et al
    Predictions of cervical cancer identification by photonic method combined with machine learning.
    Sci Rep. 2022;12:3762.
    PubMed    
    Abstract available

  98. KANG S, Wu J, Li J, Hou Q, et al
    Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis.
    Med Sci Monit. 2022;28:e934588.
    PubMed    
    Abstract available

  99. XIE X, Hu L, Liu L, Wang J, et al
    Punicalagin promotes autophagic degradation of human papillomavirus E6 and E7 proteins in cervical cancer through the ROS-JNK-BCL2 pathway.
    Transl Oncol. 2022;19:101388.
    PubMed    
    Abstract available

  100. GUPTA SM, Warke H, Chaudhari H, Mavani P, et al
    Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
    J Med Virol. 2022 Mar 7. doi: 10.1002/jmv.27700.
    PubMed    
    Abstract available

  101. ALTINEL B, Akin B
    The effect of multiple interventions for women at risk for cervical cancer on their health responsibility, beliefs regarding cervical cancer and having screening: a randomized controlled trial.
    Health Educ Res. 2022 Mar 8. pii: 6543978. doi: 10.1093.
    PubMed    
    Abstract available

  102. SWAMIDAS J, Jain J, Nesvacil N, Tanderup K, et al
    Dosimetric impact of target definition in brachytherapy for cervical cancer - Computed tomography and trans rectal ultrasound versus magnetic resonance imaging.
    Phys Imaging Radiat Oncol. 2022;21:126-133.
    PubMed    
    Abstract available

  103. SUN X, Shu Y, Ye G, Wu C, et al
    Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy.
    Acta Pharm Sin B. 2022;12:838-852.
    PubMed    
    Abstract available

  104. SEAY J, Matsuno RK, Porter B, Tannenbaum K, et al
    Cervical cancer screening compliance among active duty service members in the US military.
    Prev Med Rep. 2022;26:101746.
    PubMed    
    Abstract available

  105. SWID MA, Monaco SE
    Should screening for cervical cancer go to primary human papillomavirus testing and eliminate cytology?
    Mod Pathol. 2022 Mar 7. pii: 10.1038/s41379-022-01052.
    PubMed    
    Abstract available

  106. SU C, Zhang Y, Chen P, Yang W, et al
    Methyltransferase-like 3 induces the development of cervical cancer by enhancing insulin-like growth factor 2 mRNA-binding proteins 3-mediated apoptotic chromatin condensation inducer 1 mRNA stability.
    Bioengineered. 2022;13:7034-7048.
    PubMed    
    Abstract available

  107. PORTNOY A, Pedersen K, Nygard M, Trogstad L, et al
    Identifying a Single Optimal Integrated Cervical Cancer Prevention Policy in Norway: A Cost-Effectiveness Analysis.
    Med Decis Making. 2022 Mar 8:272989X221082683. doi: 10.1177/0272989X221082683.
    PubMed    
    Abstract available

  108. WANG B, Wang M, Jia S, Li T, et al
    Systematic Survey of the Regulatory Networks of the Long Noncoding RNA BANCR in Cervical Cancer Cells.
    J Proteome Res. 2022 Mar 7. doi: 10.1021/acs.jproteome.2c00009.
    PubMed    
    Abstract available

  109. TANAKA S, Palmer M, Katanoda K
    Trends in cervical cancer incidence and mortality of young and middle adults in Japan.
    Cancer Sci. 2022 Mar 6. doi: 10.1111/cas.15320.
    PubMed    
    Abstract available

  110. MANDAL S, Shabih S, Kumar J, Shah S, et al
    A Case Report of Advanced Cervical Cancer in a Patient Non-compliant With Age-Appropriate Screening.
    Cureus. 2022;14:e21744.
    PubMed    
    Abstract available

  111. ZENG Z, Liu J, Lv T, Feng Z, et al
    Evaluation of the efficacy of laparoscopic-assisted radical vaginal hysterectomy and abdominal radical hysterectomy for treating cervical cancer: a meta-analysis.
    Wideochir Inne Tech Maloinwazyjne. 2022;17:69-82.
    PubMed    
    Abstract available

  112. LI X, Li D, Ma R
    ALW-II-41-27, an EphA2 inhibitor, inhibits proliferation, migration and invasion of cervical cancer cells via inhibition of the RhoA/ROCK pathway.
    Oncol Lett. 2022;23:129.
    PubMed    
    Abstract available

  113. BOGDANOVA A, Andrawos C, Constantinou C
    Cervical cancer, geographical inequalities, prevention and barriers in resource depleted countries.
    Oncol Lett. 2022;23:113.
    PubMed    
    Abstract available

  114. DU Q, Xu Y, Gao XZ, Han J, et al
    [Uterine adenosarcoma with cardiac metastasis: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2022;51:262-264.
    PubMed    


  115. MIWA M, Hasegawa K
    [. Recent Trends in Chemotherapy, Targeted Therapy and Immunotherapy for Cervical Cancer and Promising New Treatments].
    Gan To Kagaku Ryoho. 2022;49:155-160.
    PubMed    


  116. NODA S, Kato S
    [.Radiotherapy for Uterine Cervical Cancer].
    Gan To Kagaku Ryoho. 2022;49:151-154.
    PubMed    


  117. MURAKAMI A, Kanao H
    [.Surgical Therapy for Uterine Cervical Cancer].
    Gan To Kagaku Ryoho. 2022;49:145-150.
    PubMed    


  118. FUJIWARA K
    [Treatment of Cervical Cancer: Past, Current, and Future].
    Gan To Kagaku Ryoho. 2022;49:143-144.
    PubMed    


  119. XIANG X, Ding Z, Zeng Q, Feng L, et al
    Dosimetric parameters and absolute monocyte count can predict the prognosis of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemotherapy and volumetric-modulated arc therapy.
    Radiat Oncol. 2022;17:48.
    PubMed    
    Abstract available

  120. WANG X, Han S, Li X, Wang X, et al
    Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52.
    Virol J. 2022;19:37.
    PubMed    
    Abstract available

  121. MACDONALD M, Mirza AS, Mhaskar R, Ewing A, et al
    Preventative Cancer Screening Rates Among Uninsured Patients in Free Clinics: A Retrospective Cohort Study of Cancer Survivors and Non-cancer Survivors.
    Cancer Control. 2022;29:10732748211072983.
    PubMed    
    Abstract available

  122. CONTRERAS-OCHOA CO, Maza-Lopez J, Mendoza de Gives P, Aguilar-Marcelino L, et al
    Cell death induction by mycelium extracts from Pleurotus spp. on cervical cancer cell lines.
    Nat Prod Res. 2022 Mar 4:1-5. doi: 10.1080/14786419.2022.2045604.
    PubMed    
    Abstract available

  123. SRIJARUSITH N, Rodpenpear N
    The Appropriate of Cone Depth in Loop Electrical Excision Procedure (LEEP) for Negative Pathological Margin from High Grade Precancerous Lesion of Cervix, Retrospective Study.
    Asian Pac J Cancer Prev. 2022;23:659-664.
    PubMed    
    Abstract available

  124. LEHTINEN M, Lagheden C, Luostarinen T, Eriksson T, et al
    Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial.
    BMJ Open. 2021;11:e050669.
    PubMed    
    Abstract available

  125. AL SHDEFAT S, Al Awar S, Osman N, Khair H, et al
    Health Care System View of Human Papilloma Virus (HPV) Vaccine Acceptability by Emirati Men.
    Comput Math Methods Med. 2022;2022:8294058.
    PubMed    
    Abstract available

  126. WISHART LM
    Non-speculum sampling for cervical screening in older women.
    Br J Gen Pract. 2022;72:58.
    PubMed    


  127. ZHAO H, He Y, Fan B, Wang Y, et al
    Human papillomavirus E6E7 mRNA and TERC lncRNA in situ detection in cervical scraped cells and cervical disease progression assessment.
    Virol J. 2022;19:18.
    PubMed    
    Abstract available

  128. ESMERAY N, Yanikkerem E
    The effect of education given to women with hearing impairments on the behaviours of Pap smear screening.
    Eur J Cancer Care (Engl). 2022;31:e13550.
    PubMed    
    Abstract available

  129. HE J, Li Q, Ma S, Li T, et al
    The polymorphism analysis and epitope predicted of Alphapapillomavirus 9 E6 in Sichuan, China.
    Virol J. 2022;19:14.
    PubMed    
    Abstract available

  130. ZHANG T, Hu R, Tang Y, Zhang Y, et al
    The effect of local photodynamic therapy with 5-aminolevulinic acid in the treatment of vaginal intraepithelial lesions with high-risk HPV infection.
    Photodiagnosis Photodyn Ther. 2022;37:102728.
    PubMed    
    Abstract available

  131. COFIE LE, Tailor HD, Lee MH, Xu L, et al
    HPV vaccination uptake among foreign-born Blacks in the US: insights from the National Health Interview Survey 2013-2017.
    Cancer Causes Control. 2022;33:583-591.
    PubMed    
    Abstract available

  132. DERBIE A, Mekonnen D, Nibret E, Maier M, et al
    Human papillomavirus genotype distribution in Ethiopia: an updated systematic review.
    Virol J. 2022;19:13.
    PubMed    
    Abstract available

  133. WANG X, Song Y, Wei X, Wang G, et al
    Prevalence and distribution of human papillomavirus genotypes among women attending gynecology clinics in northern Henan Province of China.
    Virol J. 2022;19:6.
    PubMed    
    Abstract available

  134. LANDY R, Hollingworth T, Waller J, Marlow LA, et al
    Non-speculum sampling approaches for cervical screening in older women: randomised controlled trial.
    Br J Gen Pract. 2021;72:e26-e33.
    PubMed    
    Abstract available

  135. SIRAK I, Laco J, Vosmikova H, Mell LK, et al
    SMARCA4-Deficient Carcinoma of Uterine Cervix Resembling SCCOHT-Case Report.
    Pathol Oncol Res. 2021;27:1610003.
    PubMed    
    Abstract available

  136. ZHANG M, Kiyono T, Aoki K, Goshima N, et al
    Development of an in vitro carcinogenesis model of human papillomavirus-induced cervical adenocarcinoma.
    Cancer Sci. 2022;113:904-915.
    PubMed    
    Abstract available

  137. MAMO L, Perez AE, Rios L
    Human papillomavirus self-sampling: A tool in cancer prevention and sexual health promotion.
    Sociol Health Illn. 2022;44:218-235.
    PubMed    
    Abstract available

  138. SHI W, Cheng X, Wang H, Zang X, et al
    Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies.
    BMJ Open. 2021;11:e052682.
    PubMed    
    Abstract available

  139. KIM M, Choi MC, Lee C, Na YJ, et al
    Long-term outcomes of photodynamic therapy for a positive resection margin after conization for cervical intraepithelial neoplasia grade 3.
    Photodiagnosis Photodyn Ther. 2022;37:102639.
    PubMed    
    Abstract available

  140. WANG H, Xiao R, Yang B
    MiR-101-3p Suppresses Progression of Cervical Squamous Cell Carcinoma by Targeting and Down-Regulating KPNA2.
    Technol Cancer Res Treat. 2021;20:15330338211055948.
    PubMed    
    Abstract available

  141. SALLEH H, Azli S, Khairul-Asri MG, Jagwani A, et al
    The deceiving encounter of a spontaneously ruptured urinary bladder.
    Ann R Coll Surg Engl. 2022;104:e67-e69.
    PubMed    
    Abstract available

  142. SU Y, Zhang Y, Tong Y, Zhang L, et al
    Effect and rational application of topical photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) for treatment of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia.
    Photodiagnosis Photodyn Ther. 2022;37:102634.
    PubMed    
    Abstract available

  143. GAGE JC, Raine-Bennett T, Schiffman M, Clarke MA, et al
    The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics.
    Cancer Epidemiol Biomarkers Prev. 2022;31:486-492.
    PubMed    
    Abstract available

  144. SUN H, Chen X
    MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2.
    Reprod Sci. 2022;29:203-211.
    PubMed    
    Abstract available

  145. STOLNICU S, Hoang L, Almadani N, De Brot L, et al
    Horizontal tumor extent (HZTE) has limited prognostic significance in 2018 FIGO stage I endocervical adenocarcinoma (ECA): a retrospective study of 416 cases.
    J Cancer Res Clin Oncol. 2022;148:577-586.
    PubMed    
    Abstract available

  146. YAN X, Shen L, Xiao Y, Wang Q, et al
    Prevalence, characteristics, and distribution of HPV genotypes in women from Zhejiang Province, 2016-2020.
    Virol J. 2021;18:208.
    PubMed    
    Abstract available

  147. GARGANO JW, You M, Potter R, Alverson G, et al
    An Evaluation of Dose-Related HPV Vaccine Effectiveness Using Central Registries in Michigan.
    Cancer Epidemiol Biomarkers Prev. 2022;31:183-191.
    PubMed    
    Abstract available

  148. VAN DE VEN PM, Bassi A, Berkhof J
    Comparing the sensitivities of two screening tests in nonblinded randomized paired screen-positive trials with differential screening uptake.
    Stat Med. 2021;40:6873-6884.
    PubMed    
    Abstract available

  149. TIITI TA, Mashishi TL, Nkwinika VV, Benoy I, et al
    High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.
    Virol J. 2021;18:192.
    PubMed    
    Abstract available

  150. SEONG J, Ryou S, Lee J, Yoo M, et al
    Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study.
    Virol J. 2021;18:188.
    PubMed    
    Abstract available

  151. CHUNG MH, De Vuyst H, Greene SA, Mugo NR, et al
    Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women: A Secondary Analysis of a Randomized Clinical Trial.
    JAMA Oncol. 2021;7:1514-1520.
    PubMed    
    Abstract available

  152. DRUZHKOVA I, Lukina M, Dudenkova V, Ignatova N, et al
    Tracing of intracellular pH in cancer cells in response to Taxol treatment.
    Cell Cycle. 2021;20:1540-1551.
    PubMed    
    Abstract available

  153. UEDA Y, Katayama K, Yagi A, Kimura T, et al
    The Chasm We Must Cross in Japan for Re-promotion of the HPV Vaccine.
    Cancer Prev Res (Phila). 2021;14:683-686.
    PubMed    
    Abstract available

  154. TALIA KL, Arora R, McCluggage WG
    Precursor Lesions of Cervical Clear Cell Carcinoma: Evidence For Origin From Tubo-Endometrial Metaplasia.
    Int J Gynecol Pathol. 2022;41:105-112.
    PubMed    
    Abstract available

  155. CHODICK G, Leader AE, Larson S
    Catch-up HPV Vaccination and Subsequent Uptake of Papanicolaou Testing in A State-mandated Health System.
    Cancer Prev Res (Phila). 2021;14:415-420.
    PubMed    
    Abstract available

  156. WELLS JC, Sharma S, Del Paggio JC, Hopman WM, et al
    An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries.
    JAMA Oncol. 2021;7:379-385.
    PubMed    
    Abstract available

  157. GARG A, Galvin AM, Matthes S, Maness SB, et al
    The Connection Between Social Determinants of Health and Human Papillomavirus Testing Knowledge Among Women in the USA.
    J Cancer Educ. 2022;37:148-154.
    PubMed    
    Abstract available

  158. CHEN Z, Qiu J, Gao Y, Lu Q, et al
    Study on the mechanism of let-7a-5p in regulating the proliferation in cervical cancer cells.
    Clin Transl Oncol. 2022 Mar 18. pii: 10.1007/s12094-022-02810.
    PubMed    
    Abstract available

  159. SILVERA SAN, Kaplan AM, Laforet P
    Knowledge of Human Papillomavirus and Cervical Cancer Among Low-Income Women in New Jersey.
    Public Health Rep. 2022 Mar 18:333549221081821. doi: 10.1177/00333549221081821.
    PubMed    
    Abstract available

  160. CHEN XJ, Deng YR, Wang ZC, Wei WF, et al
    Correction: Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment.
    Cell Death Dis. 2022;13:247.
    PubMed    


  161. GONG Y, Xie Y, Chen L, Sui L, et al
    Cervical Cancer in a Septate Uterus with Double Cervix and Double Vagina: A Case Report and Review of the Literature.
    Int J Womens Health. 2022;14:345-351.
    PubMed    
    Abstract available

  162. BOITANO TKL, Powell MA, Leath CA 3rd, Michael Straughn J Jr, et al
    Barriers and facilitators affecting presentation in women with early versus advanced stage cervical cancer.
    Gynecol Oncol Rep. 2022;40:100950.
    PubMed    
    Abstract available

  163. YAO G, Qiu J, Zhu F, Wang X, et al
    Survival of Patients With Cervical Cancer Treated With Definitive Radiotherapy or Concurrent Chemoradiotherapy According to Histological Subtype: A Systematic Review and Meta-Analysis.
    Front Med (Lausanne). 2022;9:843262.
    PubMed    
    Abstract available

  164. FEKRI-ERSHAD S, Ramakrishnan S
    Cervical cancer diagnosis based on modified uniform local ternary patterns and feed forward multilayer network optimized by genetic algorithm.
    Comput Biol Med. 2022;144:105392.
    PubMed    
    Abstract available

  165. JIMENEZ-CASTILLO V, Illescas-Barbosa D, Zenteno E, Avila-Curiel BX, et al
    Increased O-GlcNAcylation promotes IGF-1 receptor/PhosphatidyI Inositol-3 kinase/Akt pathway in cervical cancer cells.
    Sci Rep. 2022;12:4464.
    PubMed    
    Abstract available

  166. MANGAJ A, Chopra S, Nout RA
    Defining the role of high-dose radiation in oligometastatic & oligorecurrent cervical cancer.
    Indian J Med Res. 2021;154:303-318.
    PubMed    
    Abstract available

  167. GOPU P, Antony F, Cyriac S, Karakasis K, et al
    Updates on systemic therapy for cervical cancer.
    Indian J Med Res. 2021;154:293-302.
    PubMed    
    Abstract available

  168. BHATLA N, Singhal S, Dhamija E, Mathur S, et al
    Implications of the revised cervical cancer FIGO staging system.
    Indian J Med Res. 2021;154:273-283.
    PubMed    
    Abstract available

  169. SHYLASREE TS, Gurram L, Das U
    Para-aortic lymph node involvement in cervical cancer: Implications for staging, outcome and treatment.
    Indian J Med Res. 2021;154:0.
    PubMed    
    Abstract available

  170. KUMAR A, Chopra S, Gupta S
    Contribution of Tata Memorial Centre, India, to cervical cancer care: Journey of two decades.
    Indian J Med Res. 2021;154:0.
    PubMed    
    Abstract available

  171. GEORGE R, Rai B
    Practical aspects of palliative care & palliative radiotherapy in incurable cervical cancer.
    Indian J Med Res. 2021;154:0.
    PubMed    
    Abstract available

  172. WILKIN T, Chen H, Sahasrabuddhe V, Matining R, et al
    A randomized clinical trial of HPV test-and-treat as compared to cytology-based screening for prevention of cervical cancer among women living with HIV: AIDS Clinical Trials Group Protocol A5282.
    Clin Infect Dis. 2022 Mar 16. pii: 6549734. doi: 10.1093.
    PubMed    
    Abstract available

  173. ARCIA FRANCHINI AP, Iskander B, Anwer F, Oliveri F, et al
    Correction: The Role of Chlamydia Trachomatis in the Pathogenesis of Cervical Cancer.
    Cureus. 2022;14:c57.
    PubMed    
    Abstract available

  174. AGNIHOTRI SK, Kumar B, Jain A, Anjali A, et al
    Clinical Significance of Circulating Serum Levels of sCD95 and TNF-alpha in Cytoprotection of Cervical Cancer.
    Rep Biochem Mol Biol. 2022;10:711-721.
    PubMed    
    Abstract available

  175. SAVIRA M, Suhaimi D, Putra AE, Yusrawati Y, et al
    Prevalence Oncogenic Human Papillomavirus in Cervical Cancer Patients in Riau Province Indonesia.
    Rep Biochem Mol Biol. 2022;10:573-579.
    PubMed    
    Abstract available

  176. SWEENEY SO, Cheng Y, Botfield JR
    Renewal of the National Cervical Screening Program: health professionals' knowledge about screening of specific populations in NSW, Australia.
    Public Health Res Pract. 2022;32.
    PubMed    
    Abstract available

  177. EASTMENT MC, Gupta A, James J, Richardson BA, et al
    Cervical cancer screening, abnormal results, and follow-up in women with substance use-related diagnoses.
    Subst Abus. 2022;43:925-931.
    PubMed    
    Abstract available

  178. WANG Y, Wang C, Qiu J, Qu X, et al
    Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer.
    J Immunother Cancer. 2022;10.
    PubMed    
    Abstract available

  179. XIONG J, Nie M, Fu C, Chai X, et al
    Hypoxia Enhances HIF1alpha Transcription Activity by Upregulating KDM4A and Mediating H3K9me3, Thus Inducing Ferroptosis Resistance in Cervical Cancer Cells.
    Stem Cells Int. 2022;2022:1608806.
    PubMed    
    Abstract available

  180. PANG SS, Murphy M, Markham MJ
    Current Management of Locally Advanced and Metastatic Cervical Cancer in the United States.
    JCO Oncol Pract. 2022 Mar 14:OP2100795. doi: 10.1200/OP.21.00795.
    PubMed    
    Abstract available

  181. GUPTA N, Nehra P, Chauhan AS, Mehra N, et al
    Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India-A Model-Based Economic Analysis.
    JCO Glob Oncol. 2022;8:e2100355.
    PubMed    
    Abstract available

  182. AUSTIN J, Delgado P, Gatewood A, Enmeier M, et al
    Cervical cancer screening among women with comorbidities: a cross-sectional examination of disparities from the behavioral risk factor surveillance system.
    J Osteopath Med. 2022 Mar 14. pii: jom-2021-0044. doi: 10.1515/jom-2021-0044.
    PubMed    
    Abstract available

  183. MENGISTU A, Cherie N, Addisu E
    Determinants of positive cervical cancer screening among reproductive-age women in South Wollo Zone, Northeast Ethiopia.
    Health Sci Rep. 2022;5:e527.
    PubMed    
    Abstract available

  184. SCHNEITER MK, Levinson K, Rositch AF, Stone RL, et al
    Gynecologic oncology HPV vaccination practice patterns: Investigating practice barriers, knowledge gaps and opportunities for maximizing cervical cancer prevention.
    Gynecol Oncol Rep. 2022;40:100952.
    PubMed    
    Abstract available

  185. LEFEUVRE C, De Pauw H, Le Duc Banaszuk AS, Pivert A, et al
    Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening.
    Int J Public Health. 2022;67:1604284.
    PubMed    
    Abstract available

  186. KRISTINA SA, Endarti D, Aditama H
    Prediction of Productivity Costs Related to Cervical Cancer Mortality in Indonesia 2018.
    Malays J Med Sci. 2022;29:138-144.
    PubMed    
    Abstract available


  187. Long Non-Coding RNA LINC01783 Promotes the Progression of Cervical Cancer by Sponging miR-199b-5p to Mediate GBP1 Expression [Retraction].
    Cancer Manag Res. 2022;14:967-968.
    PubMed    
    Abstract available

  188. RICHARDS TB, Lindley MC, Byron SC, Saraiya M, et al
    Human papilloma virus vaccination and cervical cancer screening coverage in managed care plans - United States, 2018.
    Prev Med. 2022 Mar 10:107019. doi: 10.1016/j.ypmed.2022.107019.
    PubMed    
    Abstract available

  189. LI Y, Li Z, Zhang G
    Clinical Utility of Red Blood Cell Distribution Width for the Diagnosis and Prognosis of Cervical Cancer.
    Int J Gen Med. 2022;15:2597-2606.
    PubMed    
    Abstract available

  190. CHEN X, Duan H, Liu P, Lin L, et al
    Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
    Ann Transl Med. 2022;10:121.
    PubMed    
    Abstract available

  191. LIU L, Wang S, Yu T, Bai H, et al
    Value of diffusion-weighted imaging in preoperative evaluation and prediction of postoperative supplementary therapy for patients with cervical cancer.
    Ann Transl Med. 2022;10:120.
    PubMed    
    Abstract available

  192. LI J, Liang L, Xiu L, Zeng J, et al
    Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression.
    Ann Transl Med. 2022;10:125.
    PubMed    
    Abstract available

  193. LI Z, Duan H, Guo J, Yang Y, et al
    Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study.
    Ann Transl Med. 2022;10:122.
    PubMed    
    Abstract available

  194. YANG X, Yin F, Liu Q, Ma Y, et al
    Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
    Ann Transl Med. 2022;10:123.
    PubMed    
    Abstract available

  195. WANG H, Li D, Wang C, Wang X, et al
    Efficacy evaluation of vaginal-assisted laparoscopic radical hysterectomy and laparoscopic radical hysterectomy for cervical cancer: a single-center retrospective case series study.
    Ann Transl Med. 2022;10:124.
    PubMed    
    Abstract available

  196. BIRRER MJ, Fujiwara K, Oaknin A, Randall L, et al
    The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-beta and PD-L1 Pathways.
    Front Oncol. 2022;12:814169.
    PubMed    
    Abstract available

  197. ZHANG G, Liao Y, Pan X, Zhang X, et al
    Exosomes from HPV-16 E7-pulsed dendritic cells prevent the migration, M1 polarization, and inflammation of macrophages in cervical cancer by regulating catalase 2 (CAT2).
    Ann Transl Med. 2022;10:217.
    PubMed    
    Abstract available

  198. XU Y, Dong X, Ma B, Mu P, et al
    Circ_0000228 Promotes Cervical Cancer Progression via Regulating miR-337-3p /TGFBR1 Axis.
    Cell J. 2022;24:91-98.
    PubMed    
    Abstract available

  199. MA X, Ge A, Han J, Kang J, et al
    Meta-analysis of downregulated E-cadherin as a diagnostic biomarker for cervical cancer.
    Arch Gynecol Obstet. 2022 Mar 13. pii: 10.1007/s00404-022-06475.
    PubMed    
    Abstract available

  200. ZHANG Y, Song J, Liu J, Liu R, et al
    The "Hand-as-Foot" teaching method in cervical cancer staging.
    Asian J Surg. 2022 Mar 9. pii: S1015-9584(22)00148.
    PubMed    


  201. SACKEY ENS, Pemmaraju M, Griffin MR, Castilho JL, et al
    Impact of prior underinsurance on cervical cancer screening among Davidson County, Tennessee, women diagnosed with invasive cervical cancer, 2008-2018.
    BMC Womens Health. 2022;22:68.
    PubMed    
    Abstract available

  202. ZHU K, Deng C, Du P, Liu T, et al
    G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.
    Reprod Biol Endocrinol. 2022;20:50.
    PubMed    
    Abstract available

  203. CICCONI P, Wells C, McCarthy B, Wareing S, et al
    Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.
    HIV Med. 2022 Mar 3. doi: 10.1111/hiv.13257.
    PubMed    
    Abstract available

  204. TANG J, Li M, Zhao C, Shen D, et al
    Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials.
    Viruses. 2022;14.
    PubMed    
    Abstract available

  205. SUN M, Zhou D, Wu J, Zhou J, et al
    Sdy-1 Executes Antitumor Activity in HepG2 and HeLa Cancer Cells by Inhibiting the Wnt/beta-Catenin Signaling Pathway.
    Mar Drugs. 2022;20.
    PubMed    
    Abstract available

  206. ZHANG Y, Zhang X, Wang H, Shen D, et al
    Stage IA1 HPV-associated cervical squamous cell carcinoma metastasizing to ovary by special pathway: a case report and literature review.
    J Ovarian Res. 2022;15:21.
    PubMed    
    Abstract available

  207. ZHONG Y, Lan J
    Overexpression of Eukaryotic translation initiation factor 3D induces stem cell-like properties and metastasis in cervix cancer by activating FAK through inhibiting degradation of GRP78.
    Bioengineered. 2022;13:1952-1961.
    PubMed    
    Abstract available

  208. AFOULLOUSS S, Sanchez AR, Jennings LK, Kee Y, et al
    Unveiling the Chemical Diversity of the Deep-Sea Sponge Characella pachastrelloides.
    Mar Drugs. 2022;20.
    PubMed    
    Abstract available

  209. GONZALEZ-CASTILLO M, Jesus Loera M, Ascacio-Valdes J, Rodriguez-Herrera R, et al
    Punicalin and ellagic acid from pomegranate peel extract facilitate apoptotic behaviour in the Hela cell line.
    Pak J Pharm Sci. 2021;34:2181-2189.
    PubMed    
    Abstract available

  210. DUGORD C, Franc C
    Trajectories and individual determinants of regular cancer screening use over a long period based on data from the French E3N cohort.
    Soc Sci Med. 2022;294:114663.
    PubMed    
    Abstract available

  211. ANDRALOJC KM, Molina MA, Qiu M, Spruijtenburg B, et al
    Novel high-resolution targeted sequencing of the cervicovaginal microbiome.
    BMC Biol. 2021;19:267.
    PubMed    
    Abstract available

  212. LIN W, Zhang Q, Chen Y, Chen L, et al
    The prevalence of human papillomavirus and bacterial vaginosis among young women in China: a cross-sectional study.
    BMC Womens Health. 2021;21:409.
    PubMed    
    Abstract available

  213. TEODORO RP, Scherer D, de Camargo MJ, da Costa ACC, et al
    Negative histology in cervical specimens obtained with the "see and treat" method among women at a referral center in Rio de Janeiro, Brazil: a cross-sectional study.
    BMC Womens Health. 2021;21:400.
    PubMed    
    Abstract available

  214. NAMBU Y, Mariya T, Shinkai S, Umemoto M, et al
    A screening assistance system for cervical cytology of squamous cell atypia based on a two-step combined CNN algorithm with label smoothing.
    Cancer Med. 2022;11:520-529.
    PubMed    
    Abstract available

  215. WITTENBORN J, Wagels L, Kupec T, Iborra S, et al
    Anxiety in women referred for colposcopy: a prospective observational study.
    Arch Gynecol Obstet. 2022;305:625-630.
    PubMed    
    Abstract available

  216. SEZGIN B, Pirincci F, Camuzcuoglu A, Sahin EA, et al
    Evaluation of dynamic thiol-disulfide balance in preinvasive lesions of the cervix.
    Arch Gynecol Obstet. 2022;305:617-623.
    PubMed    
    Abstract available

  217. REZNICZEK GA, Neghabian N, Rehman S, Tempfer CB, et al
    Video colposcopy versus headlight for large loop excision of the transformation zone (LLETZ): a randomised trial.
    Arch Gynecol Obstet. 2022;305:415-423.
    PubMed    
    Abstract available

  218. LIU W, Li C, Rahaman MM, Jiang T, et al
    Is the aspect ratio of cells important in deep learning? A robust comparison of deep learning methods for multi-scale cytopathology cell image classification: From convolutional neural networks to visual transformers.
    Comput Biol Med. 2022;141:105026.
    PubMed    
    Abstract available

  219. LU P, Fang F, Zhang H, Ling L, et al
    AugMS-Net:Augmented multiscale network for small cervical tumor segmentation from MRI volumes.
    Comput Biol Med. 2022;141:104774.
    PubMed    
    Abstract available

  220. KEERS G, Yamada K, Pickles K, Bell K, et al
    Understanding women's choices for management of cervical intraepithelial neoplasia 2 (CIN2): Qualitative analysis of a randomised experimental study.
    Aust N Z J Obstet Gynaecol. 2022;62:125-132.
    PubMed    
    Abstract available

  221. LEHTINEN M, Apter D, Eriksson T, Harjula K, et al
    Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland.
    Cancer Med. 2021;10:7759-7771.
    PubMed    
    Abstract available

  222. DE MAGALHAES CCB, Linhares IM, Masullo LF, Eleuterio RMN, et al
    Comparative measurement of D- and L-lactic acid isomers in vaginal secretions: association with high-grade cervical squamous intraepithelial lesions.
    Arch Gynecol Obstet. 2022;305:373-377.
    PubMed    
    Abstract available

  223. MOSS JL, Popalis M, Ramirez SI, Reedy-Cooper A, et al
    Disparities in Cancer Screening: The Role of County-Level Metropolitan Status and Racial Residential Segregation.
    J Community Health. 2022;47:168-178.
    PubMed    
    Abstract available

  224. LEE F, Bukowski A, Spees LP, Wheeler SB, et al
    Prevalence of high-risk HPV by RNA assay in home self-collected samples among underscreened people in North Carolina.
    Sex Transm Dis. 2021 Sep 13. pii: 00007435-900000000-97574.
    PubMed    
    Abstract available

  225. RUFFIEUX Y, Dhokotera T, Muchengeti M, Bartels L, et al
    Cancer risk in adolescents and young adults living with HIV in South Africa: a nationwide cohort study.
    Lancet HIV. 2021;8:e614-e622.
    PubMed    
    Abstract available

  226. KIESEL M, Beyers I, Kalisz A, Wockel A, et al
    Introducing a novel model for simulating large loop excision of the transformation zone (LLETZ) using 3D printing technique.
    Arch Gynecol Obstet. 2022;305:703-712.
    PubMed    
    Abstract available

  227. BLAKE EA, Ross MS, Ross ME, Matsuo K, et al
    Immunohistochemical analysis of glassy cell carcinoma of the cervix reveals robust lymphocyte infiltrate and the expression of targetable inhibitory immune checkpoints.
    Arch Gynecol Obstet. 2022;305:439-447.
    PubMed    
    Abstract available

  228. YANG X, Qu Y, Zhang J
    Up-Regulated LncRNA FEZF1-AS1 Promotes the Progression of Cervical Carcinoma Cells via MiR-367-3p/SLC12A5 Signal Axis.
    Arch Med Res. 2022;53:9-19.
    PubMed    
    Abstract available

  229. KLAPDOR R, Hertel H, Delebinski L, Hillemanns P, et al
    Association of preoperative cone biopsy with recurrences after radical hysterectomy.
    Arch Gynecol Obstet. 2022;305:215-222.
    PubMed    
    Abstract available

  230. GONZALEZ AA, Ametorgoh A, Hamele-Bena D, Everest S, et al
    The significance of ASC-H and LSIL dual interpretation with risk stratification: one institution experience.
    J Am Soc Cytopathol. 2021;10:565-570.
    PubMed    
    Abstract available

  231. ROSITCH AF, Levinson K, Suneja G, Monterosso A, et al
    Epidemiology of cervical adenocarcinoma and squamous cell carcinoma among women living with HIV compared to the general population in the United States.
    Clin Infect Dis. 2021 Jun 18. pii: 6304858. doi: 10.1093.
    PubMed    
    Abstract available

  232. NARKCHAM S, Mody DR, Jones A, Thrall MJ, et al
    Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping.
    J Am Soc Cytopathol. 2021;10:558-564.
    PubMed    
    Abstract available

  233. RODRIGUEZ GMG, Ornelas OAO, Vazquez HMG, Esquivel DSS, et al
    Attitude and Acceptability of the Self-Sampling in HPV Carrier Women.
    Hisp Health Care Int. 2022;20:40-43.
    PubMed    
    Abstract available

  234. LINTON D
    Beliefs related to Pap smear intention among Jamaicans: A qualitative research study.
    Nurse Pract. 2021;46:51-55.
    PubMed    
    Abstract available

  235. ANDERSON LJ, Lee ASD, Daniel RG
    Improving Attitudes and Beliefs of Cervical Cancer Screening Guidelines: An Evidence-Based Quality Improvement Project.
    J Natl Black Nurses Assoc. 2021;32:28-36.
    PubMed    
    Abstract available

  236. GUO YJ, Yan XJ, Zhao HX, Wen XD, et al
    Quantitative Evaluation of the Normal Cervix, Cervical Cancer, and Cervical Precancerous Changes Via Real-Time Shear Wave Elastography.
    J Ultrasound Med. 2022 Mar 26. doi: 10.1002/jum.15981.
    PubMed    
    Abstract available

  237. ZHAO X, Wang X, Zhang B, Liu X, et al
    Classifying early stages of cervical cancer with MRI-based radiomics.
    Magn Reson Imaging. 2022 Mar 22. pii: S0730-725X(22)00041.
    PubMed    
    Abstract available

  238. ZHANG X, Zhang Q, Guo J, Zhao J, et al
    Added-value of texture analysis of ADC in predicting the survival of patients with 2018 FIGO stage IIICr cervical cancer treated by concurrent chemoradiotherapy.
    Eur J Radiol. 2022;150:110272.
    PubMed    
    Abstract available

  239. FANG F, Guo C, Zheng W, Wang Q, et al
    Exosome-Mediated Transfer of miR-1323 from Cancer-Associated Fibroblasts Confers Radioresistance of C33A Cells by Targeting PABPN1 and Activating Wnt/beta-Catenin Signaling Pathway in Cervical Cancer.
    Reprod Sci. 2022 Mar 25. pii: 10.1007/s43032-021-00820.
    PubMed    
    Abstract available

  240. DONG T, Cao X, Zhang Y, Wang Z, et al
    Effect of flurbiprofen axetil on pain and cognitive dysfunction after radical operation of cervical cancer in elderly patients.
    Minerva Surg. 2022 Mar 25. pii: S2724-5691.22.09503.
    PubMed    


  241. WAGNER-LARSEN KS, Lura N, Salvesen O, Halle MK, et al
    Interobserver agreement and prognostic impact for MRI-based 2018 FIGO staging parameters in uterine cervical cancer.
    Eur Radiol. 2022 Mar 24. pii: 10.1007/s00330-022-08666.
    PubMed    
    Abstract available

  242. MALDONADO-CARCELES AB, Belmonte Gomez MA, Cascales Perez ML, Sanchez Morales MA, et al
    [Acceptability of self-sampling as a method for cervical cancer screening among women from the Region of Murcia (Spain).]
    Rev Esp Salud Publica. 2022;96.
    PubMed    
    Abstract available

  243. KANDATI K, Belagal P, Nannepaga JS, Viswanath B, et al
    Role of probiotics in the management of cervical cancer: An update.
    Clin Nutr ESPEN. 2022;48:5-16.
    PubMed    
    Abstract available

  244. ZHAO R, Liang S, Teoh D, Fei Y, et al
    A comprehensive cross-sectional survey to identify barriers and facilitators of cervical cancer screening in women with HIV in Guangxi, China.
    Infect Agent Cancer. 2022;17:12.
    PubMed    
    Abstract available

  245. SHAW P, Senthilnathan R, Sankar S, Ilangovan I, et al
    A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis.
    Genes (Basel). 2022;13.
    PubMed    
    Abstract available

  246. KIM S, Lee H, Lee S, Song JY, et al
    Role of Artificial Intelligence Interpretation of Colposcopic Images in Cervical Cancer Screening.
    Healthcare (Basel). 2022;10.
    PubMed    
    Abstract available

  247. POURETTE D, Cripps A, Guerrien M, Despres C, et al
    Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  248. AUTORINO R, Gui B, Panza G, Boldrini L, et al
    Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
    Radiol Med. 2022 Mar 24. pii: 10.1007/s11547-022-01482.
    PubMed    
    Abstract available

  249. GURRAM L, Mohanty S, Chopra S, Grover S, et al
    Outcomes of Cervical Cancer in HIV-Positive Women Treated With Radiotherapy at a Tertiary Care Center in India.
    JCO Glob Oncol. 2022;8:e2100312.
    PubMed    
    Abstract available

  250. SHI F, Pang XX, Li GJ, Chen ZH, et al
    Genetic association study of intron variants in the forkhead box protein P3 gene in Chinese patients diagnosed with cervical cancer.
    J Cell Mol Med. 2022 Mar 24. doi: 10.1111/jcmm.17276.
    PubMed    
    Abstract available

  251. OU R, Lu S, Wang L, Wang Y, et al
    Circular RNA circLMO1 Suppresses Cervical Cancer Growth and Metastasis by Triggering miR-4291/ACSL4-Mediated Ferroptosis.
    Front Oncol. 2022;12:858598.
    PubMed    
    Abstract available

  252. SHIN HY, Lee YY, Song SY, Park B, et al
    Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005-2020.
    J Gynecol Oncol. 2022 Feb 11. pii: 33.e39. doi: 10.3802/jgo.2022.
    PubMed    
    Abstract available

  253. PARK S, Park W, Park SH, Kim JY, et al
    Oncologic outcomes according to the level of disease burden in patients with metachronous distant metastases from uterine cervical cancer: a Korean Radiation Oncology Group study (KROG 18-10).
    J Gynecol Oncol. 2022 Feb 3. pii: 33.e32. doi: 10.3802/jgo.2022.
    PubMed    
    Abstract available

  254. MACHIDA H, Matsuo K, Kobayashi Y, Momomura M, et al
    Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system.
    J Gynecol Oncol. 2022 Feb 3. pii: 33.e26. doi: 10.3802/jgo.2022.
    PubMed    
    Abstract available

  255. WEI B, Chen Y, Lu T, Cao W, et al
    Correlation between vaginal microbiota and different progression stages of cervical cancer.
    Genet Mol Biol. 2022;45:e20200450.
    PubMed    
    Abstract available

  256. MERINO GF, Altamirano RA, Herrera J, Arab C, et al
    [Molecular diagnosis of human papillomavirus infection. The Chilean experience].
    Rev Med Chil. 2021;149:1339-1346.
    PubMed    
    Abstract available

  257. NITTA Y, Murata H, Okonogi N, Murata K, et al
    Secondary cancers after carbon-ion radiotherapy and photon beam radiotherapy for uterine cervical cancer: A comparative study.
    Cancer Med. 2022 Mar 23. doi: 10.1002/cam4.4622.
    PubMed    
    Abstract available

  258. NAJAFI S
    Circular RNAs as emerging players in cervical cancer tumorigenesis; A review to roles and biomarker potentials.
    Int J Biol Macromol. 2022;206:939-953.
    PubMed    
    Abstract available

  259. JIANG Y, Hou R, Li S, Li S, et al
    MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.
    Exp Ther Med. 2022;23:298.
    PubMed    
    Abstract available

  260. SALMERON-BARCENAS EG, Zacapala-Gomez AE, Lozano-Amado D, Castro-Munoz LJ, et al
    Comprehensive bioinformatic analysis reveals oncogenic role of H2A.Z isoforms in cervical cancer progression.
    Iran J Basic Med Sci. 2021;24:1470-1481.
    PubMed    
    Abstract available

  261. SONG Z, Xing F, Jiang H, He Y, et al
    Long non-coding RNA TP73-AS1 predicts poor prognosis and regulates cell proliferation and migration in cervical cancer.
    Arch Med Sci. 2019;18:523-534.
    PubMed    
    Abstract available

  262. LEWIS RM, Naleway AL, Klein NP, Crane B, et al
    Changes in Cervical Cytology Results and Human Papillomavirus Types Among Persons Screened for Cervical Cancer, 2007 and 2015-2017.
    J Low Genit Tract Dis. 2022;26:135-139.
    PubMed    
    Abstract available

  263. GEBISA T, Bala ET, Deriba BS
    Knowledge, Attitude, and Practice Toward Cervical Cancer Screening Among Women Attending Health Facilities in Central Ethiopia.
    Cancer Control. 2022;29:10732748221076680.
    PubMed    
    Abstract available

  264. YAMAMOTO M, Motohara T, Iwagoi Y, Tayama S, et al
    Fertility-sparing surgery for early-stage cervical cancer: A case series study on the efficacy and feasibility of cervical conization followed by pelvic lymphadenectomy.
    J Obstet Gynaecol Res. 2022 Mar 21. doi: 10.1111/jog.15215.
    PubMed    
    Abstract available

  265. YANG X, Li Z, Cai Z, Tang X, et al
    Optimizing the IPSA Conditions to Improve the Treatment Plan Quality in Brachytherapy for Cervical Cancer.
    J Oncol. 2022;2022:6499744.
    PubMed    
    Abstract available

  266. THIEL DE BOCANEGRA H, Dehlendorf C, Kuppermann M, Vangala SS, et al
    Impact of an educational tool on young women's knowledge of cervical cancer screening recommendations.
    Cancer Causes Control. 2022 Mar 21. pii: 10.1007/s10552-022-01569.
    PubMed    
    Abstract available

  267. XIAO M, Li Y, Ma F, Zhang G, et al
    Multiparametric MRI radiomics nomogram for predicting lymph-vascular space invasion in early-stage cervical cancer.
    Br J Radiol. 2022 Mar 24:20211076. doi: 10.1259/bjr.20211076.
    PubMed    
    Abstract available

  268. LI Y, Gao X, Yang C, Yan H, et al
    CircRNA hsa_circ_0018289 exerts an oncogenic role in cervical cancer progression through miR-1294/ICMT axis.
    J Clin Lab Anal. 2022 Mar 21:e24348. doi: 10.1002/jcla.24348.
    PubMed    
    Abstract available

  269. BAGWELL-GRAY ME, Ramaswamy M
    Cervical Cancer Screening and Prevention among Survivors of Intimate Partner Violence.
    Health Soc Work. 2022 Mar 21. pii: 6551050. doi: 10.1093.
    PubMed    
    Abstract available

  270. BOGANI G, Chiappa V, Bini M, Ronzulli D, et al
    BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer.
    Tumori. 2022 Mar 20:3008916211073621. doi: 10.1177/03008916211073621.
    PubMed    
    Abstract available

  271. PENG Y, Liu Y, Chen Z, Zhang G, et al
    Accuracy Improvement Method Based on Characteristic Database Classification for IMRT Dose Prediction in Cervical Cancer: Scientifically Training Data Selection.
    Front Oncol. 2022;12:808580.
    PubMed    
    Abstract available

  272. ZHANG YF, Fan Y, Zhang P, Ruan JY, et al
    Cervical Cancer Recurrence and Patient Survival After Radical Hysterectomy Followed by Either Adjuvant Chemotherapy or Adjuvant Radiotherapy With Optional Concurrent Chemotherapy: A Systematic Review and Meta-Analysis.
    Front Oncol. 2022;12:823064.
    PubMed    
    Abstract available

  273. LIU J, Liu Y, Zhang Y, Zheng J, et al
    Circular RNA hsa_circ_0004543 Aggravates Cervical Cancer Development by Sponging MicroRNA hsa-miR-217 to Upregulate Hypoxia-Inducible Factor.
    J Oncol. 2022;2022:4031403.
    PubMed    
    Abstract available

  274. HUANG W, Wang Y, Yang F, Luo N, et al
    The Impaction of Laparoscopic versus Laparotomy for Lymphovascular Space Invasion of Early Cervical Cancer: A Multicenter Retrospective Study.
    Gynecol Minim Invasive Ther. 2022;11:17-22.
    PubMed    
    Abstract available

  275. WANG X, Xu C, Sun H
    DNA Damage Repair-Related Genes Signature for Immune Infiltration and Outcome in Cervical Cancer.
    Front Genet. 2022;13:733164.
    PubMed    
    Abstract available

  276. PUENTE-VALLEJO R, Ochoa P, Nunez C, De Los Reyes L, et al
    Management of an Unusual Metastasis of Cervical Cancer in the Adrenal Bed With Stereotactic Ablative Body Radiation Therapy.
    Cureus. 2022;14:e22178.
    PubMed    
    Abstract available

  277. ELKADY RM
    Radiomics Analysis in Evaluation of Cervical Cancer: A Further Step on the Road.
    Acad Radiol. 2022 Mar 17. pii: S1076-6332(22)00128.
    PubMed    


  278. FATEMI SA, Seifi N, Rasekh S, Amiri S, et al
    Immunotherapeutic approaches for HPV-caused cervical cancer.
    Adv Protein Chem Struct Biol. 2022;129:51-90.
    PubMed    
    Abstract available

  279. PHAM MA, Benkortbi K, Kenfack B, Tincho Foguem E, et al
    Recruitment strategies to promote uptake of cervical cancer screening in the West Region of Cameroon.
    BMC Public Health. 2022;22:548.
    PubMed    
    Abstract available

  280. ZHANG Z, Jiang L, Bi R, Wu X, et al
    Clinical Implication of Simultaneous Intensity-modulated Radiotherapy Boost to Tumor Bed for Cervical Cancer with Full-thickness Stromal Invasion.
    Oncologist. 2022;27:e53-e63.
    PubMed    
    Abstract available

  281. AMRAM O, Amiri S, Robison J, Pflugeisen CM, et al
    COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
    Cancer Med. 2022 Mar 18. doi: 10.1002/cam4.4655.
    PubMed    
    Abstract available

  282. ARWINI B, Tam IS, Al-Agha O, Lee JS, et al
    Clinical Conundrum: A Case of Cervical Giant Condyloma Acuminatum.
    J Obstet Gynaecol Can. 2022;44:294-297.
    PubMed    
    Abstract available

  283. ZHANG J, Zhao XM, Chen Y
    [Application of Diffusion Weighted Imaging in Pathological Grading/Typing and Clinical Staging of 95 Cases of Cervical Adenocarcinoma].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022;44:60-64.
    PubMed    
    Abstract available

  284. DEMARCO M, Egemen D, Hyun N, Chen X, et al
    Contribution of Etiologic Cofactors to CIN3+ Risk Among Women With Human Papillomavirus-Positive Screening Test Results.
    J Low Genit Tract Dis. 2022;26:127-134.
    PubMed    
    Abstract available

  285. KIM JH, Kim J, Kim K, No JH, et al
    Risk Factor and Treatment of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Intraepithelial Neoplasia.
    J Low Genit Tract Dis. 2022;26:147-151.
    PubMed    
    Abstract available

  286. KALUBULA M, Shen H, Makasa M, Liu L, et al
    Epidemiology of Cancers in Zambia: A significant variation in Cancer incidence and prevalence across the nation.
    Malawi Med J. 2021;33:186-195.
    PubMed    
    Abstract available

  287. LIU S, Li R, Liu Q, Sun D, et al
    Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer.
    Cancer Biomark. 2022;33:249-259.
    PubMed    
    Abstract available

  288. WIIK J, Karrberg C, Nilsson S, Strander B, et al
    Associations between cervical intraepithelial neoplasia during pregnancy, previous excisional treatment, cone-length and preterm delivery: a register-based study from western Sweden.
    BMC Med. 2022;20:61.
    PubMed    
    Abstract available

  289. NWANKWO C, Shah R, Shah A, Corman S, et al
    Treatment patterns and economic burden among newly diagnosed cervical and endometrial cancer patients.
    Future Oncol. 2022;18:965-977.
    PubMed    
    Abstract available

  290. KEBEDE N, Shah R, Shah A, Corman S, et al
    Treatment patterns and economic burden among cervical and endometrial cancer patients newly initiating systemic therapy.
    Future Oncol. 2022;18:953-964.
    PubMed    
    Abstract available

  291. OKUYAMA NCM, Cezar-Dos-Santos F, Trugilo KP, Esposito A, et al
    CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis.
    J Cancer Res Clin Oncol. 2022;148:793-802.
    PubMed    
    Abstract available

  292. LV X, Liu L, Li P, Yuan Y, et al
    Constructing a Novel Signature Based on Immune-Related lncRNA to Improve Prognosis Prediction of Cervical Squamous Cell Carcinoma Patients.
    Reprod Sci. 2022;29:800-815.
    PubMed    
    Abstract available

  293. YING TH, Lin CL, Chen PN, Wu PJ, et al
    Angelol-A exerts anti-metastatic and anti-angiogenic effects on human cervical carcinoma cells by modulating the phosphorylated-ERK/miR-29a-3p that targets the MMP2/VEGFA axis.
    Life Sci. 2022;296:120317.
    PubMed    
    Abstract available

  294. DOMROSE CM, Wieland U, Pilch H, Einzmann T, et al
    Cervical Intraepithelial Neoplasia 3 (Cervical Intraepithelial Neoplasia 3/High-Grade Squamous Intraepithelial Lesion) in Human Papillomavirus-Vaccinated Women-Results From a Tertiary Referral Center.
    J Low Genit Tract Dis. 2022;26:122-126.
    PubMed    
    Abstract available

  295. RAGHURAMAN S, Schubert AS, Broker S, Jurado A, et al
    Pressure Drives Rapid Burst-Like Coordinated Cellular Motion from 3D Cancer Aggregates.
    Adv Sci (Weinh). 2022;9:e2104808.
    PubMed    
    Abstract available

  296. ASENCIO AGUEDO AY, Cerrillo Alvarez GG
    [Endometrioide-type cervical adenomyoma].
    Rev Esp Patol. 2022;55:36-40.
    PubMed    
    Abstract available

  297. ZEITLIN R, Yu G, Wheatley M, Morrow N, et al
    Dosimetric predictors of local control and complications in gynecologic transperineal implant patients: The medical college of wisconsin experience.
    Brachytherapy. 2022;21:94-109.
    PubMed    
    Abstract available

  298. COLON-CARABALLO M, Lee N, Nallasamy S, Myers K, et al
    Novel regulatory roles of small leucine-rich proteoglycans in remodeling of the uterine cervix in pregnancy.
    Matrix Biol. 2022;105:53-71.
    PubMed    
    Abstract available

  299. AHMED S, Khan H, Fakhri S, Aschner M, et al
    Therapeutic potential of marine peptides in cervical and ovarian cancers.
    Mol Cell Biochem. 2022;477:605-619.
    PubMed    
    Abstract available

  300. JIN B, Kong W, Zhao X, Chen S, et al
    Substrate stiffness affects the morphology, proliferation, and radiosensitivity of cervical squamous carcinoma cells.
    Tissue Cell. 2022;74:101681.
    PubMed    
    Abstract available

  301. HE J, Liu L, Tang F, Zhou Y, et al
    Paradoxical effects of DNA tumor virus oncogenes on epithelium-derived tumor cell fate during tumor progression and chemotherapy response.
    Signal Transduct Target Ther. 2021;6:408.
    PubMed    
    Abstract available

  302. LI J, Dou Q, Yang H, Liu J, et al
    Cervical cell multi-classification algorithm using global context information and attention mechanism.
    Tissue Cell. 2022;74:101677.
    PubMed    
    Abstract available

  303. BAJWA HK, Talluri AK, Maqbool A, Reddy D, et al
    Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
    Brachytherapy. 2022;21:151-157.
    PubMed    
    Abstract available

  304. MANTOANI PTS, Vieira JF, Menchete TT, Jammal MP, et al
    CIN Extension at Colposcopy: Relation to Treatment and Blood Parameters.
    J Obstet Gynaecol Can. 2022;44:255-260.
    PubMed    
    Abstract available

  305. KITANO T
    Risk-Benefit Analysis of the 9-Valent HPV Vaccination for Adolescent Boys from an Individual Perspective.
    Jpn J Infect Dis. 2022;75:114-120.
    PubMed    
    Abstract available

  306. THAKER NG, Meghani R, Wilson C, Garey J, et al
    Impact of the Radiation Oncology Alternative Payment Model on Brachytherapy Reimbursement.
    Brachytherapy. 2022;21:55-62.
    PubMed    
    Abstract available

  307. KESKIN N, Biyik I, Ince O, Gokten H, et al
    Evaluation of the consistency ratios of cervical smear, cervical biopsy and conization results.
    Ginekol Pol. 2021;92:778-783.
    PubMed    
    Abstract available

  308. KABAN I, Bacanakgil BH, Koca S
    The comparison of two methods in cervical smear screening - which method is better for smear adequacy rates?
    Ginekol Pol. 2021;92:335-338.
    PubMed    
    Abstract available

  309. MULDER C, Rayner J
    High and Sustained Participation in a Multi-year Voluntary Performance Measurement Initiative Among Primary Care Teams.
    Int J Health Policy Manag. 2022;11:514-520.
    PubMed    
    Abstract available

  310. OLTHOF EP, Mom CH, Snijders MLH, Wenzel HHB, et al
    The prognostic value of the number of positive lymph nodes and the lymph node ratio in early-stage cervical cancer.
    Acta Obstet Gynecol Scand. 2022 Feb 26. doi: 10.1111/aogs.14316.
    PubMed    
    Abstract available

  311. ZHOU F, Chen H, Li M, Strickland AL, et al
    The Prognostic Values of HPV Genotypes and Tumor PD-L1 Expression in Patients With HPV-associated Endocervical Adenocarcinoma.
    Am J Surg Pathol. 2022;46:300-308.
    PubMed    
    Abstract available

  312. BRANDT HM, Kepka D, Kirchhoff AC, Daniel CL, et al
    Human papillomavirus (HPV) vaccination is cancer prevention for childhood cancer survivors.
    Cancer. 2021 Oct 4. doi: 10.1002/cncr.33920.
    PubMed    


  313. PINATTI LM, Gu W, Wang Y, Elhossiny A, et al
    SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.
    Cancer. 2021;127:3531-3540.
    PubMed    
    Abstract available

  314. O'ROURKE K
    Better HPV vaccination and cervical cancer screening needed.
    Cancer. 2022;128:1559.
    PubMed    


  315. VAN DEN HELDER R, Steenbergen RDM, van Splunter AP, Mom CH, et al
    HPV AND DNA METHYLATION TESTING IN URINE FOR CERVICAL INTRAEPITHELIAL NEOPLASIA AND CERVICAL CANCER DETECTION.
    Clin Cancer Res. 2022 Mar 10. pii: 682143. doi: 10.1158/1078-0432.CCR-21-3710.
    PubMed    
    Abstract available

  316. PRODROMIDOU A, Phelps DL, Pergialiotis V, Cunnea P, et al
    Clinicopathological characteristics and survival outcomes of patients with large cell neuroendocrine carcinoma of the uterine cervix: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2022;270:212-220.
    PubMed    
    Abstract available

  317. PH M, Maulard A, Scherier S, Sanson C, et al
    Oncologic results of fertility sparing surgery of cervical cancer: An updated systematic review.
    Gynecol Oncol. 2022 Feb 28. pii: S0090-8258(22)00051.
    PubMed    
    Abstract available

  318. LEITAO MM JR
    The end of routine lymphadenectomy for the treatment of cervical cancer is rapidly approaching.
    Gynecol Oncol. 2022;164:461-462.
    PubMed    


  319. BAETEN IGT, Hoogendam JP, Jonges GN, Jurgenliemk-Schulz IM, et al
    Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer.
    Gynecol Oncol. 2022 Feb 23. pii: S0090-8258(22)00121.
    PubMed    
    Abstract available

  320. HACK AP, Zweemer RP, Jonges TN, van der Leij F, et al
    Prognostic impact of waiting time between diagnosis and treatment in patients with cervical cancer: A nationwide population-based study.
    Gynecol Oncol. 2022 Mar 14. pii: S0090-8258(22)00177.
    PubMed    
    Abstract available

  321. MAYADEV JS, Ke G, Mahantshetty U, Pereira MD, et al
    Global challenges of radiotherapy for the treatment of locally advanced cervical cancer.
    Int J Gynecol Cancer. 2022;32:436-445.
    PubMed    
    Abstract available

  322. SHERER MV, Kotha NV, Williamson C, Mayadev J, et al
    Advances in immunotherapy for cervical cancer: recent developments and future directions.
    Int J Gynecol Cancer. 2022;32:281-287.
    PubMed    
    Abstract available

  323. STURDZA AE, Knoth J
    Image-guided brachytherapy in cervical cancer including fractionation.
    Int J Gynecol Cancer. 2022;32:273-280.
    PubMed    
    Abstract available

  324. MIRIYALA R, Mahantshetty U, Maheshwari A, Gupta S, et al
    Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future.
    Int J Gynecol Cancer. 2022;32:260-265.
    PubMed    
    Abstract available

  325. TSENG M, Ngoi NY, Tan DS, Tong PS, et al
    Combined modality management of advanced cervical cancer including novel sensitizers.
    Int J Gynecol Cancer. 2022;32:246-259.
    PubMed    
    Abstract available

  326. PINTO PJJ, Chen MJ, Santos Neto E, Faloppa CC, et al
    Prognostic factors in locally advanced cervical cancer with pelvic lymph node metastasis.
    Int J Gynecol Cancer. 2022;32:239-245.
    PubMed    
    Abstract available

  327. CHOU B, Prasad Venkatesulu B, Coleman RL, Harkenrider M, et al
    Management of stage I and II cervical cancer: a review.
    Int J Gynecol Cancer. 2022;32:216-224.
    PubMed    
    Abstract available

  328. TONINI F, Michel D, Foulon A
    An unusual cause of cervical bleeding.
    Int J Gynecol Cancer. 2022;32:214.
    PubMed    


  329. CHACON E, Manzour N, Zanagnolo V, Querleu D, et al
    SUCCOR cone study: conization before radical hysterectomy.
    Int J Gynecol Cancer. 2022;32:117-124.
    PubMed    
    Abstract available

  330. NASIOUDIS D, Ramirez PT
    Is prior conization the way forward to determine surgical approach? The answer is not so simple!
    Int J Gynecol Cancer. 2022;32:125-126.
    PubMed    


  331. SERRA RUBERT A, Climent MT, Llueca Abella A
    Schauta, an old technique for a new discussion.
    Int J Gynecol Cancer. 2022;32:205-206.
    PubMed    


  332. GRACE L, Sanday K, Garrett A, Land R, et al
    Vaginal vault smear cytology in detection of recurrence after hysterectomy for early cervical cancer.
    Int J Gynecol Cancer. 2022 Mar 14. pii: ijgc-2021-003302.
    PubMed    
    Abstract available

  333. LI D, Huang S, Liu K, Qin Y, et al
    Clinicopathological characteristics and survival outcomes in human papillomavirus independent cervical cancer: a propensity score matched analysis.
    Int J Gynecol Cancer. 2022 Mar 24. pii: ijgc-2021-003159.
    PubMed    
    Abstract available

  334. WILLIAMSON CW, Sirak I, Xu R, Portelance L, et al
    Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial.
    Int J Radiat Oncol Biol Phys. 2022;112:169-178.
    PubMed    
    Abstract available

  335. VAN DE SANDE AJM, Schreuder CM, van Baars R, Koeneman MM, et al
    Efficacy and Long-term Outcomes of Repeated Large Loop Excision of the Transformation Zone of the Cervix.
    Obstet Gynecol. 2022;139:417-422.
    PubMed    
    Abstract available

  336. REIJTENBAGH DMW, Godart J, de Leeuw AAC, Seppenwoolde Y, et al
    Multi-center analysis of machine-learning predicted dose parameters in brachytherapy for cervical cancer.
    Radiother Oncol. 2022 Feb 24. pii: S0167-8140(22)00107.
    PubMed    
    Abstract available

  337. HOU M, Song K, Ren J, Wang K, et al
    Comparative analysis of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in evaluating the histological grade of cervical squamous carcinoma.
    BMC Cancer. 2022;22:87.
    PubMed    
    Abstract available

  338. SONG F, Yan P, Huang X, Wang C, et al
    Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    BMC Cancer. 2022;22:42.
    PubMed    
    Abstract available

  339. JIANG AG, Cai X
    Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
    BMC Cancer. 2022;22:4.
    PubMed    
    Abstract available

  340. MKUU RS, Staras SA, Szurek SM, D'Ingeo D, et al
    Clinicians' perceptions of barriers to cervical cancer screening for women living with behavioral health conditions: a focus group study.
    BMC Cancer. 2022;22:252.
    PubMed    
    Abstract available

  341. ZHANG H, Yu R, Zhang L, Wang R, et al
    Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study.
    BMC Cancer. 2022;22:202.
    PubMed    
    Abstract available

  342. FISCHER S, Kuebler U, Abbruzzese E, Breymann C, et al
    Endogenous oestradiol and progesterone as predictors of oncogenic human papillomavirus (HPV) persistence.
    BMC Cancer. 2022;22:145.
    PubMed    
    Abstract available

  343. OMENAI SA, Ajani MA, Okolo CA
    Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients.
    PLoS One. 2022;17:e0263615.
    PubMed    
    Abstract available

  344. SALARIA D, Rolta R, Mehta J, Awofisayo O, et al
    Phytoconstituents of traditional Himalayan Herbs as potential inhibitors of Human Papillomavirus (HPV-18) for cervical cancer treatment: An In silico Approach.
    PLoS One. 2022;17:e0265420.
    PubMed    
    Abstract available

  345. CHAW L, Lee SHF, Ja'afar NIH, Lim E, et al
    Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.
    PLoS One. 2022;17:e0262213.
    PubMed    
    Abstract available

  346. ZENG J, Sun P, Ping Q, Jiang S, et al
    Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.
    PLoS One. 2022;17:e0266001.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;